Related Experiment Videos
Glial fibrillary acidic protein (GFAP) immunohistochemistry in human cortex: a quantitative study using different
G M Halliday1, K M Cullen, J J Kril
1Department of Pathology, University of Sydney, NSW, Australia.
Neuroscience Letters
|May 3, 1996
Summary
Variability in glial fibrillary acidic protein (GFAP) staining in human brain tissue was observed across different antibodies. This finding highlights the need for careful interpretation of GFAP immunohistochemistry results in research and diagnostics.
Area of Science:
- Neuroscience
- Immunohistochemistry
- Pathology
Background:
- Glial fibrillary acidic protein (GFAP) is a key biomarker for astrocytes in the central nervous system.
- Standardized immunohistochemistry protocols are crucial for reliable interpretation of GFAP expression.
Purpose of the Study:
- To investigate the variability of GFAP immunohistochemistry in formalin-fixed human brain tissue.
- To assess the impact of different commercially available GFAP antisera on staining patterns.
Main Methods:
- Standardized immunohistochemistry protocols were applied to human cerebral cortex samples.
- Four different GFAP antisera were tested on control and reactive glial samples.
- GFAP immunoreactivity was analyzed in terms of pattern, cell body staining, and process intensity.
Main Results:
- Significant differences in GFAP staining patterns were observed among the tested antisera.
- GFAP immunoreactivity increased in damaged cortices, affecting cell bodies and processes.
- Control cortex showed GFAP staining primarily on the pial surface and white matter.
Conclusions:
- The choice of GFAP antiserum significantly influences immunohistochemical results in human brain tissue.
- Observed variability in GFAP staining may explain discrepancies in previous research.
- Standardization and careful selection of antibodies are critical for accurate GFAP-based diagnostics and research.